Naseri et al., 2021 - Google Patents
The radio-europium impurities in [153Sm]-EDTMP production: a review of isolation methodsNaseri et al., 2021
- Document ID
- 9137911321749262238
- Author
- Naseri F
- Charkhi A
- Salek N
- Vosoughi S
- Publication year
- Publication venue
- Nuclear Medicine Communications
External Links
Snippet
Many human cancers predominantly metastasize to the bone which causes bone pain and other symptoms. However, the management of bone metastases is challenging. Radionuclide therapy using low-energy beta-emitting radionuclides has yielded …
- 229910052693 Europium 0 title abstract description 66
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/10—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/001—Recovery of specific isotopes from irradiated targets
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/0005—Isotope delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1255—Granulates, agglomerates, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van de Voorde et al. | Radiochemical processing of nuclear-reactor-produced radiolanthanides for medical applications | |
| Naskar et al. | Theranostic terbium radioisotopes: challenges in production for clinical application | |
| Horwitz et al. | A process for the separation of 177Lu from neutron irradiated 176Yb targets | |
| Mikolajczak et al. | Radiometals for imaging and theranostics, current production, and future perspectives | |
| US6716353B1 (en) | Method for preparing high specific activity 177Lu | |
| Loveless et al. | Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47 Sc | |
| Kazakov et al. | Separation of radioisotopes of terbium from a europium target irradiated by 27 MeV α-particles | |
| NO313180B1 (en) | Visiting alpha particles emitting radiopharmaceuticals | |
| Jalilian et al. | IAEA activities on 67Cu, 186Re, 47Sc theranostic radionuclides and radiopharmaceuticals | |
| Sobolev et al. | Radionuclides emitting short-range particles and modular nanotransporters for their delivery to target cancer cells | |
| Sadler et al. | Cutting edge rare earth radiometals: prospects for cancer theranostics | |
| KR101948404B1 (en) | Production of 43sc radionuclide and radiopharmaceuticals thereof for use in positron emission tomography | |
| Naseri et al. | The radio-europium impurities in [153Sm]-EDTMP production: a review of isolation methods | |
| JP2010502965A (en) | Methods for purifying radium from various sources | |
| Maiti et al. | Investigation on the production and isolation of 149,150,151 Tb from 12C irradiated natural praseodymium target | |
| Nelson et al. | Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy | |
| Becker et al. | Cyclotron production of 43Sc and 44gSc from enriched 42CaO, 43CaO, and 44CaO targets | |
| Grundler et al. | The metamorphosis of radionuclide production and development at paul scherrer institute | |
| Guseva | Radioisotope generators of short-lived α-emitting radionuclides promising for use in nuclear medicine | |
| Zhang et al. | Production of no-carrier-added 186Re via deuteron induced reactions on isotopically enriched 186W | |
| Saha et al. | Production of radionuclides | |
| Trapp et al. | Membrane-based microfluidic solvent extraction of Ga-68 from aqueous Zn solutions: towards an automated cyclotron production loop | |
| Dvorakova | Production and chemical processing of Lu-177 for nuclear medicine at the Munich research reactor FRM-II | |
| Vosoughi et al. | Preparation of 166 Dy/166 Ho-chitosan as an in vivo generator for radiosynovectomy | |
| Kazakov | Terbium Isotopes in Nuclear Medicine: Production, Recovery, and Application |